发明名称 RXR HOMODIMER FORMATION, BRIDGED BICYCLIC AROMATIC COMPOUND, AND THEIR USE IN MODULATED GENE EXPRESSION
摘要 PROBLEM TO BE SOLVED: To provide a method for screening a substance for the ability to exert an influence on the formation of a retinoid X receptor homodimer comprising a step for combining the substance and a solution containing retinoid X receptors and a step for determining the presence of homodimer formation. SOLUTION: The method for screening a substance for the ability to exert an influence on the formation of a retinoid X receptor homodimer comprises a step to combine the substance and a solution containing retinoid X receptors and a step to determine the presence of homodimer formation, and includes a step to determine the presence of the homodimer formation by detecting the activation of transcription by the retinoid X receptor homodimer. COPYRIGHT: (C)2007,JPO&INPIT
申请公布号 JP2007001982(A) 申请公布日期 2007.01.11
申请号 JP20060192124 申请日期 2006.07.12
申请人 LIGAND PHARMACEUTICALS INC 发明人 PHAHL MAGNUS;ZHANG XIAO-KUN;LEHMANN JURGEN M;DAWSON MARCIA I;CAMERON JAMES F;HOBBS PETER D;JONG LING
分类号 C07C63/04;G01N33/50;A61K31/19;A61K31/192;A61K31/216;A61K31/335;A61K31/357;A61K31/36;A61K31/38;A61K31/381;A61K31/385;A61K31/39;A61P3/00;A61P3/02;A61P5/12;A61P17/00;A61P17/02;A61P17/06;A61P17/12;A61P19/00;A61P31/12;A61P35/00;A61P35/02;A61P37/00;A61P43/00;C07C63/49;C07C63/66;C07C65/36;C07C69/738;C07C69/76;C07C233/64;C07D311/58;C07D317/30;C07D319/04;C07D319/06;C07D327/04;C07D333/22;C07D333/38;C07D333/40;C07D339/06;C07D339/08;C07D409/04;C07K14/705;C12N15/09;C12Q1/02;C12Q1/68;G01N33/15;G01N33/53;G01N33/566;G01N33/68;G01N33/74 主分类号 C07C63/04
代理机构 代理人
主权项
地址